Abstract
We have studied the use of sulprostone in evacuating uterine contents in 32 patients, the majority of whom were in the second trimester of their pregnancies. There are three ways to administer the drug (continuous intravenous, intermittent intravenous, and intramuscular); the best results were obtained when the drug was administered continuously intravenously. It was well tolerated, the use of Nalbuphine reducing pain. There were few side effects. The use of this product is discussed in connection with a few of the cases as well as the possible alternative treatments in difficult cases.
MeSH terms
-
Abortifacient Agents, Nonsteroidal / administration & dosage*
-
Abortion, Induced*
-
Adolescent
-
Adult
-
Cicatrix / complications
-
Contraindications
-
Dinoprostone / administration & dosage
-
Dinoprostone / analogs & derivatives*
-
Drug Tolerance
-
Female
-
France
-
Gestational Age
-
Humans
-
Hydatidiform Mole / diagnosis
-
Infusions, Intravenous
-
Injections, Intramuscular
-
Injections, Intravenous
-
Mifepristone / administration & dosage
-
Misoprostol / administration & dosage
-
Polyhydramnios / diagnosis
-
Pregnancy
-
Retrospective Studies
-
Time Factors
-
Uterine Diseases / complications
-
Uterine Neoplasms / diagnosis
Substances
-
Abortifacient Agents, Nonsteroidal
-
Misoprostol
-
Mifepristone
-
sulprostone
-
Dinoprostone